Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1198.7000 -7.40 (-0.61%)
NSE Jan 09, 2026 15:31 PM
Volume: 889.1K
 

logo
Aurobindo Pharma Ltd.
28 May 2025
1198.70
-0.61%
buy
by Axis Direct
Target: 1500 | Upside : 25.1%
Axis Direct
We maintain our BUY recommendation on Aurobindo Pharma with a TP of Rs 1,500/share.
 
Number of FII/FPI investors decreased from 728 to 700 in Sep 2025 qtr
More from Aurobindo Pharma Ltd.
Recommended
Five Interesting Stocks Today - January 9, 2026
The Baseline | 09 Jan 2026
Market closes lower, dragged down by foreign investor outflows and rising crude prices
Trendlyne Marketwatch | 09 Jan 2026
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020